Fdps - farnesyl diphosphate synthetase Gene
Also Known as Fdpsl1; mKIAA1293; 6030492I17Rik
Species: Mus musculus
Summary
Predicted to enable dimethylallyltranstransferase activity and geranyltranstransferase activity. Predicted to be involved in farnesyl diphosphate biosynthetic process; positive regulation of cell growth involved in cardiac muscle cell development; and positive regulation of Cholesterol biosynthetic process. Predicted to act upstream of or within Cholesterol biosynthetic process. Located in mitochondrion. Is expressed in several structures, including alimentary system; genitourinary system; integumental system; nervous system; and sensory organ. Human ortholog(s) of this gene implicated in porokeratosis. Orthologous to human FDPS (farnesyl diphosphate synthase). [provided by Alliance of Genome Resources, Apr 2022]
Fdps Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001253751.1 | NP_001240680.1 | farnesyl pyrophosphate synthase isoform 1 precursor |
| NM_134469.4 | NP_608219.1 | farnesyl pyrophosphate synthase isoform 2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
farnesyl pyrophosphate synthase |
|
|
Recombinant Fdps Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P75196 | FDPS Protein, Mouse (His) | Q920E5 (M1-K353) | ≥ 95%, as determined by reducing SDS-PAGE. |
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-106950A | Fosfructose trisodium | 98.0% | Unkown | |
| HY-148077 | Phosphoglycolohydroxamic acid | Inhibitor | 98.0% | Unkown |
| HY-B0631S | Alendronic acid-d6 | 98.0% | Unkown | |
| HY-RS04853 | FDPS Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17189 | Fdps Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23640 | Fdps Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service